---
title: "Asenapine - Schizophrenia"
sidebar: mydoc_sidebar
permalink: db06216-mesh-d012559-1.html
toc: false 
---


Path ID: `DB06216_MESH_D012559_1`
{% include image.html url="images/db06216-mesh-d012559-1.png" file="db06216-mesh-d012559-1.png" alt="db06216-mesh-d012559-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C522667 | Asenapine | Drug |
| UniProt:P28223 | 5-hydroxytryptamine receptor 2A | Protein |
| UniProt:P14416 | D(2) dopamine receptor | Protein |
| HP:0000716 | Depressivity | PhenotypicFeature |
| REACT:R-HSA-390651 | Dopamine receptors | Pathway |
| MESH:D012559 | Schizophrenia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Asenapine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2A |
| Asenapine | DECREASES ACTIVITY OF | D(2) Dopamine Receptor |
| 5-Hydroxytryptamine Receptor 2A | POSITIVELY CORRELATED WITH | Depressivity |
| D(2) Dopamine Receptor | POSITIVELY CORRELATED WITH | Dopamine Receptors |
| Depressivity | OCCURS IN | Schizophrenia |
| Dopamine Receptors | CORRELATED WITH | Schizophrenia |
|---------|-----------|---------|

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/27356921/](https://pubmed.ncbi.nlm.nih.gov/27356921/)
  - [https://go.drugbank.com/drugs/DB06216#BE0000451](https://go.drugbank.com/drugs/DB06216#BE0000451)
  - [https://en.wikipedia.org/wiki/5-HT2A_receptor](https://en.wikipedia.org/wiki/5-HT2A_receptor)
